SANTEN PHARMA.SANTEN PHARMA.SANTEN PHARMA.

SANTEN PHARMA.

No trades
See on Supercharts
Market capitalization
‪3.31 B‬EUR
‪−103.86 M‬EUR
‪1.94 B‬EUR
‪312.65 M‬
Beta (1Y)
0.31

About SANTEN PHARMA.

CEO
Takeshi Ito
Headquarters
Osaka
Employees (FY)
‪4.14 K‬
Founded
1890
ISIN
JP3336000009
FIGI
BBG000C2JZX7
Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SANTEN PHARMA. stocks are traded under the ticker SZD.
SANTEN PHARMA. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
SZD earnings for the last quarter are 0.15 EUR per share, whereas the estimation was 0.08 EUR resulting in a 82.94% surprise. The estimated earnings for the next quarter are 0.11 EUR per share. See more details about SANTEN PHARMA. earnings.
SANTEN PHARMA. revenue for the last quarter amounts to ‪464.77 M‬ EUR despite the estimated figure of ‪418.17 M‬ EUR. In the next quarter revenue is expected to reach ‪473.22 M‬ EUR.
Yes, you can track SANTEN PHARMA. financials in yearly and quarterly reports right on TradingView.
SZD net income for the last quarter is ‪47.05 M‬ EUR, while the quarter before that showed ‪56.13 M‬ EUR of net income which accounts for −16.18% change. Track more SANTEN PHARMA. financial stats to get the full picture.
Like other stocks, SZD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANTEN PHARMA. stock right from TradingView charts — choose your broker and connect to your account.
SZD reached its all-time high on Jan 15, 2020 with the price of 18.10 EUR, and its all-time low was 1.60 EUR and was reached on May 27, 2003.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has ‪4.14 K‬ employees. See our rating of the largest employees — is SANTEN PHARMA. on this list?
We've gathered analysts' opinions on SANTEN PHARMA. future price: according to them, SZD price has a max estimate of 13.24 EUR and a min estimate of 7.82 EUR. Read a more detailed SANTEN PHARMA. forecast: see what analysts think of SANTEN PHARMA. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANTEN PHARMA. EBITDA is ‪455.91 M‬ EUR, and current EBITDA margin is 17.66%. See more stats in SANTEN PHARMA. financial statements.